Royal Sense Ltd

BSE: 544143 · Healthcare · 24 announcements

Share price: ₹68.00
Market cap: ₹36.38 Cr
Revenue (annual): ₹103.4 Cr
Net profit (annual): ₹7.15 Cr
P/E (TTM): 5.1×Sector 54.5×
Promoter holding: 62.24%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Share Pledge 3 Management Change 3 Board Meeting Date 3 Product Launch 2 Price Movement Clarification 2 Other Announcement 2 Financial Results 2 Board Meeting Outcome 2 Annual General Meeting 2 Fund Raise 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 May 2026 15:59 IST BSE

Product Launch

Royal Sense Product Launch

Royal Sense Limited launched seven new pharmaceutical products and a digital blood pressure monitor for the domestic market. The expansion strengthens its healthcare product portfolio.

Open announcement → Read the filing ↗

27 Apr 2026 13:51 IST BSE

Product LaunchAlfa Alert

Royal Sense Ltd launched 17 new pharmaceutical products, including Vitamin D3 shots, multivitamins, liver tonics, and dermatological creams. Available for sale from April 27, 2026, these products cater to the domestic market. This expansion significantly broadens the company's healthcare portfolio across high-growth nutraceutical and therapeutic segments.

Open announcement → Read the filing ↗